BIONTECH SE (BNTX)
Today's Latest Price: $121.08 USD
Updated Dec 3 12:57pm
Add BNTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BioNTech SE (BNTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNTX.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 9 | $113.18 | $17.79 | $84.25 | $114.01 | -26.1% |
BNTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 6 | 0 | 4 | 0 | 0 | 11 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNTX as an investment opportunity.
- The upside potential (average analyst target price relative to current price) of BNTX is greater than 2.91% of all US stocks.
- BNTX has a less variance in analysts' estimates than 2.84999999999999% of stocks in the large market cap category.
- BioNTech SE's average analyst price target is greater than 89.65% of Pharmaceutical Products stocks.
- BioNTech SE's percent of analysts bearish on the stock is less than 13.1% of Pharmaceutical Products stocks.
- BNTX has a greater number of analysts covering the stock than 14.82% of stocks in the large market cap category.
- BioNTech SE's percentage of analysts bullish on the stock is higher than 20.46% of Pharmaceutical Products stocks.
- BioNTech SE's change in bullishness amongst analysts is lower than almost 100% of all US stocks.
In the Pharmaceutical Products industry, DNLI, AMRN and WVE are the three stocks most similar to BioNTech SE regarding the price target and analyst recommendation information presented here.
What is the outlook for BNTX? Use POWR Ratings for clearer insight into price direction.
